BRIEF published on 06/03/2026 at 00:05, 5 months 15 days ago Onco-Innovations Achieves Key Milestone in ONC010 Manufacturing Clinical Development ONC010 Manufacturing B4 Precursor Production Dalton Pharma Collaboration Market Awareness Strategy
BRIEF published on 06/03/2026 at 00:05, 5 months 15 days ago Onco-Innovations franchit une étape clé dans la fabrication de l'ONC010 Développement Clinique Fabrication ONC010 Production Du Précurseur B4 Collaboration Avec Dalton Pharma Stratégie De Sensibilisation Au Marché
BRIEF published on 06/02/2026 at 22:40, 5 months 15 days ago Hycroft Reports $10 Billion NPV Amidst New Silver Discoveries Technical Report NPV Gold And Silver Prices Hycroft Mining Silver Discoveries
BRIEF published on 06/02/2026 at 22:40, 5 months 15 days ago Hycroft annonce une VAN de 10 milliards de dollars grâce à de nouvelles découvertes d'argent Rapport Technique Prix De L'or Et De L'argent Hycroft Mining VAN Découvertes D'argent
BRIEF published on 06/02/2026 at 22:35, 5 months 15 days ago INEO Tech Corp. Announces Share Consolidation Details TSX Venture Exchange Share Consolidation Equity Conversion Financing Plan INEO Tech Corp.
BRIEF published on 06/02/2026 at 22:35, 5 months 15 days ago INEO Tech Corp. annonce les détails de son regroupement d'actions Bourse De Croissance TSX Plan De Financement Regroupement D'actions Conversion D'actions INEO Tech Corp.
BRIEF published on 06/02/2026 at 22:35, 5 months 15 days ago Nanobiotix Reports Q1 2026 Operational and Financial Progress NSCLC Financial Update NANOBIOTIX JNJ-1900 AACR 2026
BRIEF published on 06/02/2026 at 22:35, 5 months 15 days ago Nanobiotix annonce ses progrès opérationnels et financiers pour le premier trimestre 2026. Mise À Jour Financière NANOBIOTIX JNJ-1900 AACR 2026 CBNPC
BRIEF published on 06/02/2026 at 22:35, 5 months 15 days ago Nanobiotix : Bilan du premier trimestre 2026 Biotechnologie Augmentation De Capital Essais Cliniques Nanotechnologie NBTXR3
BRIEF published on 06/02/2026 at 22:35, 5 months 15 days ago Nanobiotix: Review of the first quarter of 2026 Biotechnology Clinical Trials Capital Increase Nanotechnology NBTXR3
Published on 11/18/2026 at 07:30, 3 hours 7 minutes ago Tocvan Defines Priority Gold Target Areas at Gran Pilar From Project-Wide Soil Sampling and Geologic Mapping; 225 Soils at or Above 100 ppb Gold
Published on 11/18/2026 at 00:35, 10 hours 2 minutes ago Route1 Appoints Tom Park to Board of Directors and Announces Board Changes
Published on 11/17/2026 at 23:40, 10 hours 57 minutes ago AI/ML Innovations Inc. Closes First Tranche of Private Placement
Published on 11/17/2026 at 23:00, 11 hours 37 minutes ago Alset AI Ventures Inc. Announces Extension of Annual General Meeting Deadline
Published on 11/17/2026 at 21:30, 13 hours 7 minutes ago Fairplay Ventures INC. Announces Filing of Filing Statement in Connection With Qualifying Transaction
Published on 11/18/2026 at 10:22, 14 minutes ago EQS-Adhoc: BOOSTER Precision Components Holding announces postponement of interest payment and repayment of bond
Published on 11/18/2026 at 10:05, 31 minutes ago Lam Research, LEGO® Education Partner to Expand Access to STEM Learning for Kids; Lam Named Founding Sponsor of LEGO® League
Published on 11/18/2026 at 10:05, 31 minutes ago Human behaviour remains a critical blind spot in insider risk, new Signpost Six report warns
Published on 11/18/2026 at 10:00, 36 minutes ago Drägerwerk AG & Co. KGaA: Dräger presents Ambition 2030: EUR 4.5 billion in net sales and a 10 to 12 percent EBIT margin
Published on 11/18/2026 at 09:59, 37 minutes ago Dr Mohsen Sohi to step down as Chairman of the Supervisory Board of KION at year-end
Published on 11/18/2026 at 07:45, 2 hours 52 minutes ago Successful pricing of US$ 10 billion of bonds as part of the financing of the PTC acquisition
Published on 11/18/2026 at 07:45, 2 hours 52 minutes ago Succès de l’émission obligataire de 10 milliards dollars américains dans le cadre du financement de l’acquisition de PTC